Stockscreener 앱 받기
21.45
0.19%
-0.04
시간 외 거래:
21.45
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Geode Capital Management LLC Sells 27,061 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Purchased by Barclays PLC - MarketBeat
Denali Therapeutics upgraded to Buy from Hold at Stifel - Yahoo Finance
Y Intercept Hong Kong Ltd Sells 25,369 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Shares Gap UpTime to Buy? - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Upgraded to Buy at Stifel Nicolaus - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Average PT from Brokerages - MarketBeat
Nomura Asset Management Co. Ltd. Buys Shares of 65,033 Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
State Street Corp Sells 182,779 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
When (DNLI) Moves Investors should Listen - Stock Traders Daily
We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Simply Wall St
Point72 Asset Management L.P. Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Wellington Management Group LLP Has $312.49 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Starts Dosing in Phase II Parkinson's Disease Study - MSN
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? - Yahoo Finance
Temasek Holdings Private Ltd Lowers Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Holocene Advisors LP Has $2.84 Million Stake in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
The Manufacturers Life Insurance Company Has $6.03 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Charles Schwab Investment Management Inc. Trims Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Announces First Participant Dosed in - GlobeNewswire
Denali Therapeutics Launches Key Phase 2a Trial for Breakthrough Parkinson's Treatment - StockTitan
26,900 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Erste Asset Management GmbH - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Position Boosted by Cinctive Capital Management LP - MarketBeat
Fmr LLC Purchases 7,596,508 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Wasatch Advisors LP Reduces Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Fred Alger Management LLC - MarketBeat
Denali Therapeutics Getting Closer To Key Technical Measure - MSN
Algert Global LLC Has $1.42 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
29,543 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Intech Investment Management LLC - MarketBeat
Fisher Asset Management LLC Buys 69,223 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
PTC halts development of ALS drug after trial miss - The Pharma Letter
Victory Capital Management Inc. Has $1.16 Million Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Objective long/short (DNLI) Report - Stock Traders Daily
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Consensus PT from Analysts - MarketBeat
Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - MSN
Denali Therapeutics updates bylaws, aligns with SEC rules - Investing.com India
Denali Therapeutics updates bylaws, aligns with SEC rules By Investing.com - Investing.com UK
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat
Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha
Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire
FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com
BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada
Denali Therapeutics executive sells shares worth $465,286 - Investing.com India
Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Canada
Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
2.88%
2.65%
자본화:
|
볼륨(24시간):